CD36 and ischemic stroke: This hypothesis is supported by a study demonstrating an increase in the extent of injury in mice lacking CD36 after acute neonatal stroke [43] and on the other hand by a study in which genetic deletion of CD36 provided benefit in a transient model of ischemic stroke [13].